MEDIUM confidence: 100% data completeness, but the composite (43) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $16.1B— | $5.6B-65.4% | $14.3B+157.4% | $21.6B+51.1% | $19.3B-11.0% |
| EPS (dil.) | $7.42— | $-0.79-110.6% | $4.09n/m | $3.28-19.8% | $2.34-28.7% |
| Free Cash Flow | -$7.3B— | -$5.4Bn/m | -$1.6Bn/m | $6.5Bn/m | $9.5B+46.3% |
| Gross Margin | 42.8% | 36.1%-6.8pp | 33.9%-2.1pp | 17.8%-16.2pp | 41.8%+24.1pp |
| Operating Margin | 30.8% | -6.2%-37.0pp | 14.9%+21.1pp | 4.3%-10.6pp | 2.4%-1.9pp |
| Net Margin | 29.4% | -9.4%-38.8pp | 26.1%+35.4pp | 14.2%-11.8pp | 12.3%-1.9pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $126 (last qtr, 8 analysts) → $129 (last mo, 6) (+2.1%).
Buy-rated share 86% → 86% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.43 | $1.63 | +14.0% |
| May 2026 | $1.26 | $1.39 | +10.3% |
| Feb 2026 | $1.14 | $1.12 | -1.8% |
| Nov 2025 | $1.30 | $1.41 | +8.5% |
| Jul 2025 | $1.14 | $1.18 | +3.5% |
| May 2025 | $1.13 | $1.15 | +1.8% |
| Feb 2025 | $1.30 | $1.32 | +1.5% |
| Oct 2024 | $1.20 | $1.38 | +15.0% |
Net insider $45.7M over 180 days (12 open-market buys, 0 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 5.3%/yr (revenue basis).
Base free cash flow $4.8B (avg FY2023–FY2025; latest year $9.5B) · equity value $99.6B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 43 for KKR indicates a neutral outlook, with the stock's value and profitability scores being offset by weaker growth and risk metrics. KKR scores high on momentum, driven by its recent 3-month return of 11.5% and an RSI of 72.9, but its growth score is dragged down by negative revenue and EPS growth. The stock trades at a premium, with a P/E of 33.0 and P/B of 3.2, and exhibits moderate profitability, with an ROE of 10.3% and FCF yield of 8.5%. The long-term and short-term scores are relatively aligned, with only a 3-point difference.